1/37
Comprehensive vocabulary flashcards covering the etiology, pathophysiology, diagnostic testing, medical management, acute coronary syndromes, and chronic coronary syndromes of Ischemic Heart Disease.
Ischemic Heart Disease (IHD)
A cardiac condition characterized by an imbalance between myocardial oxygen supply and demand, resulting in myocardial hypoxia and the accumulation of waste metabolites.
Atherosclerosis
A chronic inflammatory response of large and medium-sized arteries to endothelial injury, responsible for >90% of ischemic heart disease cases.
Fatty Streak
An early stage in atherogenesis characterized by the subendothelial accumulation of lipid-laden macrophages, known as foam cells.
Vulnerable Plaque
An unstable atheromatous lesion characterized by a thin fibrous cap and a large lipid-rich core, which is highly prone to rupture or erosion and acute thrombosis.
Stable Plaque
An atheroma characterized by a thick fibrous cap covering a lipid core, producing fixed luminal obstruction that causes predictable exertional symptoms without acute thrombosis.
The Ischemic Cascade
The chronological sequence of pathophysiological events during ischemia, progressing from perfusion defect to diastolic dysfunction, systolic wall motion abnormalities, ECG changes, and ultimately angina pectoris.
CAD Equivalent
A designation applied to Diabetes Mellitus due to its promotion of diffuse, multi-vessel atherosclerosis with a cardiovascular risk profile comparable to established coronary artery disease.
Angina Equivalent
A symptom of myocardial ischemia other than typical chest tightness, most commonly exertional dyspnea, fatigue, or diaphoresis.
Levine's Sign
A classic clinical sign wherein a patient holds a clenched fist over the sternum when describing the quality of ischemic chest discomfort.
Canadian Cardiovascular Society (CCS) Class III Angina
A clinical classification denoting marked limitation of ordinary physical activity, with angina provoked by walking 1 to 2 blocks on level ground or climbing 1 flight of stairs at a normal pace.
Corneal Arcus
A greyish-white lipid ring deposit around the corneal periphery, indicating dyslipidemia when observed in individuals aged <50 years.
Bruce Protocol
A standardized exercise stress test protocol involving progressive increases in treadmill speed and grade every 3 minutes.
Target Heart Rate (Exercise Tolerance Test)
The diagnostic threshold required for a valid exercise tolerance test, defined as achieving at least 85% of the age-predicted maximal heart rate (220−Age).
Coronary Steal Phenomenon
The redistribution of myocardial blood flow away from stenotic, maximally dilated vessels toward healthy vessels following the administration of vasodilators like adenosine or dipyridamole during stress testing.
Agatston Score
A numerical scoring system derived from CT coronary calcium scoring that quantifies calcified plaque burden, where a score of 0 makes obstructive coronary artery disease highly unlikely.
Left Internal Mammary Artery (LIMA)
The gold-standard arterial conduit used in CABG to bypass Left Anterior Descending (LAD) artery lesions, exhibiting a patency rate of >90% at 10 years.
Saphenous Vein Graft (SVG)
A venous bypass conduit harvested from the leg and typically used to revascularize the RCA or Circumflex artery, with an expected patency rate of approximately 50% at 10 years.
Ivabradine
A second-line anti-anginal drug that selectively inhibits the hyperpolarization-activated cyclic nucleotide-gated (If) current in the sinoatrial node, lowering heart rate exclusively in patients in sinus rhythm without altering blood pressure or contractility.
Nicorandil
A dual-action anti-anginal agent functioning as a potassium (K+) channel opener and a nitrate-like venodilator, with a characteristic adverse effect of painful mucosal (oral and anal) ulcerations.
Ranolazine
An anti-anginal drug that selectively inhibits the late inward sodium (Na+) current, reducing intracellular calcium overload and diastolic wall tension without affecting heart rate or systemic blood pressure.
Type 1 Myocardial Infarction
A spontaneous myocardial infarction caused by atherosclerotic plaque disruption (rupture, erosion, or ulceration) with superimposed intraluminal coronary thrombosis.
Type 2 Myocardial Infarction
Myocardial necrosis resulting from an acute mismatch between oxygen supply and demand (such as profound anemia, tachyarrhythmia, severe hypotension, or vasospasm) without acute plaque rupture.
Unstable Angina (UA)
An acute coronary syndrome presenting as rest, new-onset severe, or crescendo angina characterized by transient ischemia without detectable myocardial necrosis (negative troponin).
NSTEMI
An acute coronary syndrome defined by subendocardial myocardial necrosis with elevated cardiac troponin levels, typically caused by severe but incomplete coronary occlusion or distal embolization, without persistent ST-segment elevation.
STEMI
An acute coronary syndrome resulting from acute, total coronary artery occlusion that leads to transmural myocardial necrosis, manifested on ECG by persistent ST-segment elevation (>20 minutes) or new LBBB.
Killip Classification
A clinical staging system used to stratify heart failure severity and mortality in acute myocardial infarction, progressing from Class I (no heart failure signs) to Class IV (cardiogenic shock).
Pardee Waves
Convex-upward, tall ST-segment elevations seen on a 12-lead ECG, serving as the pathognomonic sign of transmural acute myocardial injury during a STEMI.
High-Sensitivity Cardiac Troponin (hs-cTn)
The gold-standard cardiac biomarker for diagnosing myocardial necrosis, which becomes detectable within 2 to 3 hours, peaks at 24 to 48 hours, and remains elevated for 10 to 14 days.
GRACE Score
A clinical scoring system incorporating variables like age, heart rate, blood pressure, creatinine, Killip class, cardiac arrest, and ST deviation to guide the timing of invasive angiography in NSTEMI/UA.
Dressler's Syndrome
A late, autoimmune-mediated pleuropericarditis occurring 2 to 6 weeks after an acute myocardial infarction, typically presenting with fever, pleuritic chest pain, and pericardial effusion.
Papillary Muscle Rupture
A catastrophic mechanical complication occurring 3 to 7 days post-MI that produces acute severe mitral regurgitation, sudden pulmonary edema, and a new harsh pansystolic murmur.
Free Wall Rupture
A fatal mechanical complication occurring 3 to 7 days post-MI characterized by rupture of the necrotic ventricular myocardium, producing hemopericardium, acute cardiac tamponade, and sudden electromechanical dissociation.
Stunned Myocardium
Viable myocardium that exhibits persistent post-ischemic contractile dysfunction despite the complete, prompt restoration of normal coronary blood flow, recovering spontaneously over days to weeks.
Hibernating Myocardium
Viable myocardium subjected to chronic, severe hypoperfusion that downregulates its contractile activity and metabolism to preserve cell survival, regaining function only following successful revascularization.
Late Gadolinium Enhancement (LGE)
A cardiac MRI technique for myocardial viability where gadolinium contrast is retained by fibrous scar (appearing bright/white), with transmural scar exceeding >50% wall thickness indicating non-viable tissue.

Vasospastic Angina (Prinzmetal's Angina)
A form of angina caused by transient, focal spasm of an epicardial coronary artery, occurring typically at rest or at night and characterized on ECG by transient ST-segment elevation that resolves with nitroglycerin.
Microvascular Angina (INOCA)
Ischemia with Non-Obstructive Coronary Arteries characterized by a clinical triad of typical exertional angina, objective ischemia on stress testing, and angiographically normal coronary arteries due to coronary microvascular dysfunction (<500μm vessels).
Silent Ischemia
Objective electrocardiographic or imaging evidence of myocardial ischemia occurring in the complete absence of chest pain or anginal equivalents, particularly prevalent in patients with diabetes mellitus and elderly individuals.